DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global HIV Epidemiology and Patient Flow Analysis - 2017" report to their offering.
The results of the HIV patients study are announced in this new report. The report provides insights into HIV epidemiology, HIV diagnosed patients, and HIV treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of HIV derived from epidemiological analysis, percentage of patients diagnosed with HIV, and percentage of patients treated with a therapy.
The study helps executives estimate HIV market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of HIV prevalence, HIV diagnosis rate, and HIV treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan.
Key Features of the Report:
- HIV Patient Flow
- HIV Prevalence
- HIV Diagnosed Patients
-
HIV Treated Patients
Key Topics Covered:
1. HIV: Disease Definition
2. Global HIV Patient Flow
3. HIV Patient Flow in the US
4. HIV Patient Flow in Europe
5. HIV Patient Flow in Germany
6. HIV Patient Flow in France
7. HIV Patient Flow in Spain
8. HIV Patient Flow in Italy
9. HIV Patient Flow in UK
10. HIV Patient Flow in Japan
11. Research Methodology
For more information about this report visit http://www.researchandmarkets.com/research/sthvng/global_hiv
